VIR
Vir Biotechnology, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Vir Biotechnology (VIR) Stock: Buy, Sell, or Hold?
$12.27
-0.86 (-6.55%)
▼
5d:
+11.34%
30d:
+17.87%
90d:
+32.79%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
53/100
Position
EXTENDED
30-Day Fair Range
$10.50 – $12.27
Position: EXTENDED
Forward P/E & Valuation
-5.6x
Next 12M consensus est.
Wall Street Target
$22.50
+71.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$10.98 / $14.38
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: VIR shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When VIR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: VIR is currently trading at $12.27, which is considered extended relative to its 30-day fair value range of $10.50 to $12.27.
Technical Outlook: Technically, VIR is in a uptrend. Immediate support is located at $10.98, while resistance sits at $14.38. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: VIR scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $22.50 (+71.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VIR is in a uptrend. Immediate support is located at $10.98, while resistance sits at $14.38. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: VIR scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $22.50 (+71.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.50 -
$12.27
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
21.1%
Trading Range & Key Levels
30-Day Trading Range
$10.50 -
$12.27
Current vs Trading Range
EXTENDED
Support Level
$10.98
Resistance Level
$14.38
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (34/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.5%)
- BULLISH: Trading 71.4% below Wall St target ($22.50)
- WARNING: Composite score 53/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.59
Wall Street Target
$22.50
(+71.4%)
Revenue Growth (YoY)
19582.5%
Earnings Growth (YoY)
58.5%
Profit Margin
-61.0%
Share VIR Analysis
Share this live VIR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VIR)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
VIR stock surged after the company announced compelling evidence of best-in-class efficacy in the Phase 3 ECLIPSE-1 trial for Elebsiran and Tobevibart in Chronic Hepatitis Delta. All patients in the Solstice study achieved undetectable virus levels after 96 weeks.
Key Retail Themes:
Positive clinical trial results
Buyout buzz
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:15 PM ET
Data refreshes hourly during market hours. Next update: 3:15 PM
Data refreshes hourly during market hours. Next update: 3:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VIR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 64 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
|
STRO
Sutro Biopharma |
STRONG BUY
14 analysts |
$47 | 58 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VIR Research Pages
